IKTINHIBIKASE THERAPEUTICS INC
CUSIP 45719W205 · common stock
2 tracked investors held INHIBIKASE THERAPEUTICS INC (IKT) at the end of Q3 2026, worth $26.1M in total. The largest holder was RA Capital Management, with 0.1% of its portfolio. RA Capital Management opened a new position this quarter.
Holders · Q3 2026
2
New holders
1
Value held
$26.1M
Quarter-end price (est.)
$2.06
Investors holding IKT · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| RA Capital Management RA Capital Management, L.P. | 0.14% | 6,970,000 | $14.3M | NEW |
| Adar1 Capital Management ADAR1 Capital Management, LLC | 0.50% | 5,708,755 | $11.7M | REDUCE-22.7% |